NASDAQ Gainers: Growing Stock Report Initiates a NASDAQ Gainers Watch List Adding BIOLASE, Inc. and ARCA Biopharma, Inc

New York, NY -- (SBWIRE) -- 02/06/2013 -- Growing Stock Report initiates a NASDAQ Gainers Watch List adding the followign stocks: BIOLASE, Inc. (NASDAQ:BIOL) and ARCA biopharma, Inc. (NASDAQ:ABIO)

BIOLASE, Inc. (NASDAQ:BIOL) a company that develops, manufactures, and markets lasers systems for dental and medical applications and procedures in the United States and internationally is currently up (+22.26%) on news that earlier today Biolase received FDA clearance for its 940nm Diolase 10 diode soft tissue laser for a broad spectrum of medical procedures. This news and price increase in the stock has prompted Growing Stock Report to add BIOLASE, Inc. (NASDAQ:BIOL) to their NASDAQ gainers watch list.

Click Here to find out what The Street and other Investors are saying about BIOLASE, Inc.

ARCA biopharma, Inc. (NASDAQ:ABIO) a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases is currently up (+17.70%) after the company provided an update on a proposed clinical trial for atrial fibrallation for the company's flagship drug Gencaro. Currently, ABIO is up (+195.65%) up from its 52-week low. This news and increase in the stock price has prompted Growing Stock Report to add ARCA biopharma, Inc. (NASDAQ:ABIO) to their NASDAQ Gainers Watch List.

Click Here to see what other investors are saying about ARCA biopharma, Inc.

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report